| Not Yet Recruiting | An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome Lowe Syndrome | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy Plaque Psoriasis | Phase 3 | 2025-06-01 |
| Recruiting | Namodenoson Treatment of Advanced Pancreatic Cancer Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 2 | 2024-11-10 |
| Recruiting | Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhos Hepatocellular Carcinoma, Cirrhosis | Phase 3 | 2023-03-15 |
| Recruiting | Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) NASH - Nonalcoholic Steatohepatitis | Phase 2 | 2021-12-10 |
| Completed | Piclidenoson for Treatment of COVID-19 COVID-19, Coronavirus Infection | Phase 2 | 2021-01-06 |
| Withdrawn | Safety &Efficacy of CF101 to Subjects With Uveitis Uveitis, Posterior, Uveitis, Intermediate | Phase 2 | 2019-01-01 |
| Withdrawn | A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee Osteoarthritis of the Knee | Phase 2 | 2018-11-01 |
| Completed | CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2018-09-15 |
| Completed | A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease Non-alcoholic Steatohepatitis (NASH) | Phase 2 | 2017-11-27 |
| Terminated | CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2017-10-30 |
| Completed | Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Ca Hepatocellular Carcinoma | Phase 2 | 2014-09-01 |
| Completed | Trial of CF101 to Treat Patients With Dry Eye Disease Keratoconjunctivitis Sicca | Phase 3 | 2011-07-01 |
| Completed | Trial of CF101 to Treat Patients With Psoriasis Plaque Psoriasis | Phase 2 / Phase 3 | 2011-07-01 |
| Completed | Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure Ocular Hypertension, Glaucoma | Phase 2 | 2010-10-01 |
| Completed | Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2010-10-01 |
| Completed | A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 Chronic Hepatitis C | Phase 1 / Phase 2 | 2009-07-01 |
| Completed | A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2009-02-01 |
| Completed | Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients Rheumatoid Arthritis | Phase 2 | 2008-02-01 |
| Completed | Safety and Efficacy Study of CF101 to Treat Psoriasis Plaque Psoriasis | Phase 2 | 2007-06-01 |
| Completed | Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca Keratoconjunctivitis Sicca | Phase 2 | 2007-01-01 |
| Completed | Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients Rheumatoid Arthritis | Phase 2 | 2006-06-01 |